Welcome to our dedicated page for Calumet SEC filings (Ticker: CLMT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Calumet, Inc. filings document operating results, governance matters and capital-structure actions for a Nasdaq-listed specialty products and renewable fuels company. The record includes Form 8-K disclosures for quarterly and annual results, Regulation FD communications, material definitive agreements, credit-agreement amendments, direct financial obligations and senior-note transactions involving subsidiaries Calumet Specialty Products Partners, L.P. and Calumet Finance Corp.
Proxy materials describe annual meeting voting matters, board elections and related governance disclosures. The filings also identify Calumet's common stock, par value $0.01 per share, under symbol CLMT on The Nasdaq Stock Market LLC and provide formal disclosure around debt terms, covenant changes, risk-related governance and shareholder matters.
Heritage Group, a 10% owner of Calumet, Inc., reported a cashless exercise of warrants to purchase 1,020,000 shares of common stock at $20.00 per share. The issuer withheld 626,998 shares to pay the exercise price and issued the remaining 393,002 shares of common stock to the reporting person.
After these transactions, the filing shows 13,607,209 shares of common stock held directly, plus 1,200,000 shares owned by The Heritage Group Investment Company, LLC and 882,974 shares held by Calumet, Incorporated, both attributed as indirect holdings with beneficial ownership disclaimed except for any pecuniary interest.
Calumet, Inc. reported a much larger loss for the three months ended March 31, 2026 as higher compliance and hedging costs outweighed slightly higher sales. Sales rose to $1,029.7 million from $993.9 million, but cost of sales increased to $1,117.2 million, producing a gross loss of $87.5 million.
Net loss nearly doubled to $317.0 million from $162.0 million, with diluted loss per share widening to $3.64 from $1.87. Results were hit by a $115.4 million loss on derivative instruments, $115.9 million of RINs mark-to-market loss and $31.5 million of RINs incurrence expense.
Operating activities used $86.2 million of cash, while investing used $13.7 million and financing provided $73.4 million. Total debt was $2,332.0 million at March 31, 2026, including $825.2 million under the DOE Loan, and stockholders’ equity was negative $1,043.2 million. The RINs obligation increased to $316.7 million from $169.3 million.
Calumet, Inc. reported a much wider net loss for the first quarter of 2026 as non-cash RIN and derivative charges weighed on results. Net loss was $317.0 million versus $162.0 million a year earlier, with basic loss per share at $3.64 versus $1.87. Sales rose modestly to $1,029.7 million from $993.9 million, but cost of sales increased faster, driving a gross loss of $87.5 million.
Adjusted EBITDA declined to $27.6 million from $38.1 million, while Adjusted EBITDA with Tax Attributes was $50.1 million compared with $55.0 million. Management highlighted strong specialty and Performance Brands volumes but cited rapid feedstock cost increases and an unplanned Shreveport outage that cut about 750,000 barrels of production.
By segment, Specialty Products and Solutions Adjusted EBITDA fell to $44.3 million, Performance Brands to $12.6 million, while Montana/Renewables Adjusted EBITDA with Tax Attributes improved to $10.2 million. Net cash used in operating activities was $86.2 million versus $29.3 million a year earlier. Long-term debt (less current portion) increased to $2,299.4 million, and total liabilities exceeded total assets, leaving stockholders’ equity at $(1,043.2) million as of March 31, 2026.
Calumet, Inc. is asking stockholders to vote at its June 2, 2026 virtual annual meeting on electing three Class II directors, approving 2025 executive pay on an advisory basis, and ratifying Grant Thornton LLP as auditor for 2026.
Management highlights 2025 as a transition year, with revenue of $4.1 billion, a net loss of $33.8 million, and Adjusted EBITDA with Tax Attributes of $293.3 million, up about 28%. The company reduced restricted group debt by more than $220 million, retired 2026 and 2027 notes, and issued $405 million of notes due 2031.
Montana Renewables secured a $1.44 billion DOE Loan Guarantee Agreement and is pursuing a MaxSAF expansion expected to add 120–150 million gallons of annual sustainable aviation fuel with an estimated $20–$30 million of capital in Q2 2026. The proxy also details a revamped, performance-based executive compensation program and strong 2025 say‑on‑pay support of about 97%.
Calumet, Inc. director Daniel J. Sajkowski sold 3,310 shares of common stock in an open-market transaction. The sale occurred on April 1, 2026 at a weighted average price of $34.46 per share, with individual trade prices ranging from $33.75 to $35.84.
The transaction was effected under a Rule 10b5-1 trading plan adopted on November 18, 2025, when Calumet, Inc. stock closed at $19.08 per share. After this sale, Sajkowski directly holds 81,958 shares of Calumet, Inc. common stock.
Morical Gregory J reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. (CLMT) senior vice president and general counsel Gregory J. Morical received two grants of restricted stock units. One award covers 1,002 Restricted Stock Units that are 100% vested and economically equal to 1,002 shares of common stock, to be settled on a date he specifies or on his termination.
A second award covers 334 Restricted Stock Units, each equal to one share of common stock, to be settled under the Deferred Compensation Plan on the earlier of a specified date or his termination date. For this award, 25% of the units vest on July 1 of each year beginning on July 1, 2027.
Fleming Bruce A reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. executive Bruce A. Fleming reported awards of restricted stock units tied to the company’s common stock. On March 31, 2026, he received 13,047 restricted stock units that are 100% vested and will be settled on the earlier of a date he specifies or his termination date.
On the same date, he also received 4,349 restricted stock units under a Deferred Compensation Plan that will be settled on the earlier of a specified date or his termination. For this award, 25% of the units vest on July 1 of each year beginning on July 1, 2027. Each unit is the economic equivalent of one share of Calumet, Inc. common stock, so these are compensation-related equity grants rather than open-market share purchases or sales.
Borgmann Louis Todd reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. chief executive officer Louis Todd Borgmann reported awards of restricted stock units that function as stock-based compensation, not open-market trades. He received 7,173 restricted stock units and 2,391 restricted stock units, each economically equivalent to one share of Calumet, Inc. common stock.
The 7,173-unit grant is already 100% vested and will be settled in shares upon the earlier of a date he specifies or his termination date. The 2,391-unit grant will vest in 25% increments each July 1 beginning in 2027 and will be settled on the earlier of a specified date or his termination under the company’s Deferred Compensation Plan.
Krutz John Robert reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc.’s Chief Accounting Officer John Robert Krutz reported two compensation-related equity awards in the form of restricted stock units. He received 931 Restricted Stock Units, each equal to one share of common stock, which are 100% vested and will be settled on a date he specifies or upon his termination.
He also received 310 Restricted Stock Units that will be settled under the company’s Deferred Compensation Plan on the earlier of a specified date or his termination, with 25% of these units vesting on July 1 of each year beginning on July 1, 2027.